Product Information

MORPHINE SULFATE ER 20 MG CAP is a generic product labeled by Upsher-Smith Laboratories LLC, priced at $3.0808 per EA under NDC 00832022600. Its NADAC has been published 650 times since Mar 12, 2014.

FDA first approved this application on Jun 3, 2013.

MORPHINE SULFATE ER 20 MG CAP

Morphine Sulfate
$3.0808per EA
DEA Schedule CII

Strength

20 mg/1

NDC

00832022600

Classification

Generic

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

6/17/2026

Active Ingredients

MORPHINE SULFATE

Approval Type

Generic (ANDA)

FDA Application

ANDA202104

FDA Approved

6/3/2013

On Market Since

6/30/2013

Pharmacological Classes

Full Opioid Agonists
Opioid Agonist

Price Statistics

The NADAC for MORPHINE SULFATE ER 20 MG CAP has been published 650 times since Mar 12, 2014, and over the history we have for it it has declined 23.5%. The table below summarizes its recorded NADAC range and movement.

Current price$3.0808 per EA
All-time high$4.5120 (Aug 12, 2015)
All-time low$1.4058 (Feb 19, 2020)
52-week high$3.3960
52-week low$2.9419
Median price$3.0139
Average price$3.0082
Largest weekly change+111.1% (Oct 21, 2020)
Weeks tracked650
Tracking sinceMar 12, 2014

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

-8.5%

1Y

+4.7%

3Y

+5.9%

5Y

-5.9%

All

-23.5%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Morphine Sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of MORPHINE SULFATE ER 20 MG CAP?

The current National Average Drug Acquisition Cost (NADAC) for MORPHINE SULFATE ER 20 MG CAP, manufactured by Upsher-Smith Laboratories LLC, is $3.0808 per EA (NDC 00832022600), effective Aug 19, 2026.

How has the price of MORPHINE SULFATE ER 20 MG CAP changed over time?

Over the history we have for it, the NADAC for MORPHINE SULFATE ER 20 MG CAP has declined 23.5%. It has been tracked across 650 weekly CMS publications since Mar 12, 2014.

What are the highest and lowest recorded NADAC prices for MORPHINE SULFATE ER 20 MG CAP?

Since Mar 12, 2014, the NADAC for MORPHINE SULFATE ER 20 MG CAP has ranged from a low of $1.4058 (Feb 19, 2020) to a high of $4.5120 (Aug 12, 2015), with a median of $3.0139 per EA.

Are there cheaper alternatives to MORPHINE SULFATE ER 20 MG CAP?

No other NADAC-published product currently shares the active ingredient and strength of MORPHINE SULFATE ER 20 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures MORPHINE SULFATE ER 20 MG CAP?

MORPHINE SULFATE ER 20 MG CAP (NDC 00832022600) is labeled by Upsher-Smith Laboratories LLC, and CMS classifies it as a generic product.